Stability challenges of amorphous solid dispersions of drugs: A critical review on mechanistic aspects

M Pisay, S Padya, S Mutalik… - Critical Reviews™ in …, 2024 - dl.begellhouse.com
The most common drawback of the existing and novel drug molecules is their low
bioavailability because of their low solubility. One of the most important approaches to …

The persistence and crystallization behavior of atorvastatin calcium amorphous dispersions in polyvinylpyrrolidone

C Tizaoui, H Galai, S Clevers, N Couvrat… - Journal of Drug Delivery …, 2022 - Elsevier
The persistence of amorphous atorvastatin calcium has been studied as a function of the
amorphization method, polymer content, and relative humidity during storage. For …

[HTML][HTML] The Value of Bead Coating in the Manufacturing of Amorphous Solid Dispersions: A Comparative Evaluation with Spray Drying

E Boel, F Reniers, W Dehaen, G Van den Mooter - Pharmaceutics, 2022 - mdpi.com
Despite the fact that an amorphous solid dispersion (ASD)-coated pellet formulation offers
potential advantages regarding the minimization of physical stability issues, there is still a …

Gaining insight into the role of the solvent during spray drying of amorphous solid dispersions by studying evaporation kinetics

S Dedroog, P Adriaensens… - Molecular …, 2022 - ACS Publications
Spray drying is one of the most commonly used manufacturing techniques for amorphous
solid dispersions (ASDs). During spray drying, very fast solvent evaporation is enabled by …

[PDF][PDF] Investigation of bead coating as manufacturing process for the development of amorphous solid dispersions

E Boel - 2023 - lirias.kuleuven.be
The number of drug molecules that show poor aqueous solubility and low dissolution rate
has significantly increased during the past two decades, resulting in low oral bioavailability …

[PDF][PDF] Influence of formulation and process parameters on the kinetic stabilization of amorphous solid dispersions with high drug loading

S Dedroog, G Van den Mooter - 2022 - lirias.kuleuven.be
A drawback of the current drug selection procedures is their high output of drug candidates
with unfavorable physicochemical properties12. More specifically, ca. 70% of new drug …